Nutritional status is associated with disease progression in very mild Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 22, Issue 1, 2008, Pages 66-71

  Ousset, Pierre Jean ^a   Nourhashemi, Fati ^a   Reynish, Emma ^a   Vellas, Bruno ^a  

^a CHU PURPAN   (France)

Author keywords

Nutritional status; Progression; Very mild Alzheimer disease

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; CLINICAL DEMENTIA RATING SCALE; COGNITION; CONFIDENCE INTERVAL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRIORITY JOURNAL; RATING SCALE; RISK;

AGED; ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NUTRITIONAL STATUS; PSYCHIATRIC STATUS RATING SCALES;

EID: 43249122446     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31815a9dbb     Document Type: Article

References (65)

1. Leifer B. Early diagnosis of Alzheimer's disease: clinical and economic benefits. J Am Geriatr Soc. 2003;51:281-288.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
4. Tariot PN, Federoff HJ. Current treatment for Alzheimer disease and future prospects. Alzheimer Dis Assoc Disord. 2003;17:105-113.
5. Salmon DP, Thomas RG, Pay MM, et al. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology. 2002;59:1022-1028.
6. Kraemer HC, Tinklenberg J, Yesavage JA. "How far" vs "how fast" in Alzheimer's disease. The question revisited. Arch Neurol. 1994;51:275-279.
7. Hui JS, Wilson RS, Bennett DA, et al. Rate of cognitive decline and mortality in Alzheimer's disease. Neurology. 2003;61:1356-1361.
8. Amieva H, Letenneur L, Dartigues JF, et al. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord. 2004;18:87-93.
9. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9:65-69.
10. Meguro K, Shimada M, Yamaguchi S, et al. Neuropsychosocial features of very mild Alzheimer's disease (CDR 0.5) and progression to dementia in a community: the Tajiri project. J Geriatr Psychiatry Neurol. 2004;17:183-189.
11. Storandt M, Grant EA, Miller JP, et al. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 2002;59:1034-1041.
12. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging. 2003;7:91-96.
13. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
14. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
15. Katz S, Ford AB, Moskowitz RW, et al. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
16. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
17. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
18. Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;2:116-122.
19. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med. 2002;18:737-757.
20. Bleda MJ, Bolibar I, Pares R, et al. Reliability of the mini nutritional assessment (MNA) in institutionalized elderly people. J Nutr Health Aging. 2002;6:134-137.
21. Guigoz Y, Vellas B, Gary PJ. Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev. 1996;54:59-65.
22. Guigoz Y, Vellas B. Test to assess the nutritional status of the elderly: the Mini Nutritional Assessment (MNA). Med Hyg. 1995;53:1965-1969.
23. Persson MD, Brismar KE, Katzarski KS, et al. Nutritional status using mini nutritional assessment and subjective global assessment predict mortality in geriatric patients. J Am Geriatr Soc. 2002;50:1996-2002.
24. Ruiz-Lopez MD, Artacho R, Oliva P, et al. Nutritional risk in institutionalized older women determined by the Mini Nutritional Assessment test: what are the main factors? Nutrition. 2003;19:767-771.
25. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
26. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
27. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405.
28. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
29. Meguro K, Ishii H, Yamaguchi S, et al. Prevalence and cognitive performances of clinical dementia rating 0.5 and mild cognitive impairment in Japan. The Tajiri project. Alzheimer Dis Assoc Disord. 2004;18:3-10
30. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
31. Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol. 2004;3:579-587.
32. Wolf-Klein GP, Silverstone FA. Weight loss in Alzheimer's disease: an international review of the literature. Int Psychogeriatr. 1994;6:135-142.
33. Du W, DiLuca C, Growdon JH. Weight loss in Alzheimer's disease. J Geriatr Psychiatry Neurol. 1993;6:34-38.
34. Reyes-Ortega G, Guyonnet S, Ousset PJ, et al. Weight loss in Alzheimer's disease and resting energy expenditure (REE), a preliminary report. J Am Geriatr Soc. 1997;45:1414-1415.
35. White H, Pieper C, Schmader K, et al. Weight change in Alzheimer's disease. J Am Geriatr Soc. 1996;44:265-272.
36. Sandman PO, Adolfsson R, Nygren C, et al. Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multiinfarct dementia. J Am Geriatr Soc. 1987;35:31-38.
37. Doty RL. Olfactory deficit in Alzheimer's disease? Am J Psychiatry. 2001;158:1533-1534.
38. Berlinger WG, Potter JF. Low Body Mass Index in demented outpatients. J Am Geriatr Soc. 1991;39:973-978.
39. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46:1223-1227.
40. Franklin CA, Karkeck J. Weight loss and senile dementia in an institutionalized elderly population. J Am Diet Assoc. 1989;89:790-792.
41. Guyonnet S, Nourhashemi F, Ousset PJ, et al. Factors associated with weight loss in Alzheimer's disease. J Nutr Health Aging. 1998;2:107-109.
42. Barrett-Connor E, Edelstein S, Corey-Bloom J, et al. Weight loss precedes dementia in community-dwelling older adults. J Nutr Health Aging. 1998;2:113-114.
43. Ball MJ, Fisman M, Hachinski V, et al. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet. 1985;1:14-16.
44. Riviere S, Gillette-Guyonnet S, Nourhashemi F, et al. Nutrition and Alzheimer's disease. Nutr Rev. 1999;57:363-367.
45. Grundman M, Corey-Bloom J, Jernigan T, et al. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 1996;46:1585-1591.
46. Wang PN, Yang CL, Lin KN, et al. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. J Neurol. 2004;251:314-320.
47. Jansson ET. Alzheimer disease is substantially preventable in the United States-review of risk factors, therapy, and the prospects for an expert software system. Med Hypotheses. 2005;64:960-967.
48. Reynish W, Andrieu S, Nourhashemi F, et al. Nutritional factors and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2001;56:675-680.
49. Backman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 2001;124:96-102.
50. Marra C, Silveri MC, Gainotti G. Predictors of cognitive decline in the early stage of probable Alzheimer's disease. Dement Geriatr Cogn Disord. 2000;11:212-218.
51. Mortimer JA, Gosche KM, Riley KP, et al. Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study. Neurology. 2004;62:428-432.
52. Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758-764.
53. Burns A, Jacoby R, Levy R. Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc. 1991;39:39-45.
54. Teri L, Hughes JP, Larson EB. Cognitive deterioration in Alzheimer's disease: behavioral and health factors. J Gerontol. 1990;45:58-63.
55. Daly E, Zaitchik D, Copeland M, et al. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol. 2000;57:675-680.
56. Chui HC, Lyness SA, Sobel E, et al. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol. 1994;51:676-681.
57. Stern Y, Mayeux R, Sano M, et al. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987;37:1649-1653.
58. Gallagher-Thompson D, Brooks JO III, Bliwise D, et al. The relations among caregiver stress, "sundowning" symptoms, and cognitive decline in Alzheimer's disease. J Am Geriatr Soc. 1992;40:807-810.
59. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278.
60. Stern Y, Brandt J, Albert M, et al. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol. 1997;41:615-620.
61. Lee DY, Youn JC, Choo IH, et al. Combination of clinical and neuropsychologic information as a better predictor of the progression to Alzheimer disease in questionable dementia individuals. Am J Geriatr Psychiatry. 2006;14:130-138
62. Adak S, Illouz K, Gorman W, et al. Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology. 2004 13;63:108-114.
63. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82:636-643.
64. Morris MC, Evans DA, Tangney CC, et al. Fish consumption and cognitive decline with age in a large community study. Arch Neurol. 2005;62:1849-1853.
65. Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br J Nutr. 2001;86:313-321.